Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F9FD0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,229
Award facts
- Contract value 100% obligated
- $44,228.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,228.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of SKYRIZI 150 MG/ML (risankizumab), a biologic medication used to treat inflammatory conditions including plaque psoriasis, Crohn's disease, and ulcerative colitis. This non-competitive delivery order, which is scheduled for completion by December 11, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreements with the Defense Logistics Agency. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. The delivery order reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, demonstrating the company's capacity to fulfill urgent medical procurement requirements through established contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26F9FD0?
SPE2DR26F9FD0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F9FD0 worth?
The government has obligated $44,229 on SPE2DR26F9FD0.
Is contract SPE2DR26F9FD0 an order under another contract?
Yes. SPE2DR26F9FD0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FD0 competed?
The extent of competition for SPE2DR26F9FD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award